62554 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 

Environmental Health (CUG), insert the 

following: 

Office of Communication (CUG12). 

The Office of Communication (OC): (1) 

Serves as the principal advisor to the 

center director and divisions on 

communication and marketing science, 

research, practice, and public affairs; (2) 

leads center strategic planning for 

communication and marketing science 

and public affairs programs and 

projects; (3) analyzes context, situation, 

and environment to inform center-wide 

communication and marketing programs 

and projects; (4) ensures use of 

scientifically sound research for 

marketing and communication programs 

and projects; (5) ensures accurate, 

accessible, timely, and effective 

translation of science for use by 

multiple audiences; (6) leads 

identification and implementation of 

information dissemination channels; (7) 

provides communication and marketing 

project management expertise; (8) 

collaborates with external organizations 

and the news, public service, and 

entertainment and other media to 

ensure that scientific findings and their 

implications for public health reach the 

intended audiences; (9) collaborates 

closely with divisions to produce 

materials tailored to meet the 

requirements of news and other media 

channels, including press releases, 

letters to the editor, public service 

announcements, television 

programming, video news releases, and 

other electronic and printed materials; 

(10) coordinates the development and 

maintenance of accessible public 

information through the Internet, social 

media and other applicable channels; 

(11) provides training and technical 

assistance in the areas of health 

communication, risk communication, 

social marketing, and public affairs; (12) 

manages or coordinates communication 

services such as broadcast, graphics, 

photography, writing, and editing; (13) 

provides editorial services, including 

writing, editing, and technical editing; 

(14) facilitates internal communication 

to center staff and allied audiences; (15) 

supervises and manages OC activities, 

programs, and staff; (16) serves as 

liaison to internal and external groups 

to advance the center’s mission; (17) 

collaborates with the CDC Office of the 

Associate Director for Communication 

on media relations, electronic 

communication, health media 

production, and brand management 

activities; (18) collaborates with the 

Office of Public Health Preparedness 

and Response and other NCEH/ATSDR 

entities to fulfill communication 

responsibilities in emergency response 

situations; (19) collaborates with other 

CDC Centers/Institute/Offices in the 

development of marketing 

communications targeted to populations 

that would benefit from a crossfunctional approach; and (20) ensures 

NCEH/ATSDR materials meet CDC and 

Department of Health and Human 

Services standards. 

Dated: September 27, 2010. 

William P. Nichols, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2010–25223 Filed 10–8–10; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 75 FR 59277–59278, 

dated September 25, 2010) is amended 

to reflect the reorganization of the 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention, 

Office of Infectious Diseases, Centers for 

Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the function 

statements for the National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention (CJV) and the Office of the 

Director (CJV1) and insert the following: 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention 

(CJV). The National Center for HIV/ 

AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP) maximizes 

public health and safety nationally and 

internationally through the elimination, 

prevention, and control of disease, 

disability, and death caused by Human 

Immunodeficiency Virus Infection/ 

Acquired Immunodeficiency Syndrome 

(HIV/AIDS), non-HIV retroviruses, viral 

hepatitis, other sexually transmitted 

diseases (STDs), and tuberculosis (TB). 

In carrying out its mission, NCHHSTP: 

(1) Builds capacity and enhances public 

health infrastructure for preventing and 

treating HIV/AIDS, viral hepatitis, STDs, 

and TB; (2) coordinates activities and 

programs across CDC and with other 

Department of Health and Human 

Services Operational Divisions in order 

to maximize the public health impact of 

HIV/AIDS, viral hepatitis, STDs, and TB 

interventions; (3) conducts surveillance 

and research to determine the 

distribution, determinants, and burden 

of HIV/AIDS, viral hepatitis, STDs, and 

TB; (4) conducts program evaluation to 

improve programs and activities relating 

to the prevention of HIV/AIDS, viral 

hepatitis, STDs, and TB, and determine 

their impact; (5) provides reference 

laboratory and clinical diagnostic 

services for HIV/AIDS, viral hepatitis, 

STDs, and TB to relevant stakeholders; 

(6) promotes collaboration and service 

integration among HIV/AIDS, viral 

hepatitis, STDs, and TB programs; (7) 

engages external partners to develop 

and implement effective HIV/AIDS, 

viral hepatitis, STDs, and TB policies, 

research, and programs; (8) engages 

partners, to promote health equity and 

reduce health disparities among those 

affected by HIV/AIDS, viral hepatitis, 

STDs, and TB; (9) provides technical 

assistance and training in the diagnosis, 

treatment, and prevention of HIV/AIDS, 

viral hepatitis, STDs, and TB; (10) 

conducts public health communication 

activities to disseminate research 

findings and increase awareness of HIV/ 

AIDS, viral hepatitis, STDs, and TB; (11) 

conducts operational, behavioral, and 

biomedical research to improve the 

distribution, diagnosis, prevention, and 

control of HIV/AIDS, viral hepatitis, 

STDs, and TB; (12) provides scientific 

leadership regarding public health 

ethics and protection of human subjects 

linked to HIV/AIDS, viral hepatitis, 

STDs, and TB; (13) translates research 

findings into public health practice and 

policy for HIV/AIDS, viral hepatitis, 

STDs, and TB prevention; (14) plans, 

coordinates, and guides programs and 

activities with external partners, federal 

agencies, and other organizations 

related to HIV/AIDS, viral hepatitis, 

STDs, and TB prevention, care, and 

treatment; (15) leads and participates in 

the development, implementation, and 

evaluation of policies and guidelines 

related to HIV/AIDS, viral hepatitis, 

STDs, and TB; (16) provides scientific 

leadership regarding screening, 

treatment, immunization, and other 

prevention interventions relevant to 

HIV/AIDS, viral hepatitis, STDs, and 

TB; (17) assures all public health 

decisions are based on the highest 

quality scientific data, openly and 

objectively derived; (18) provides 

leadership to assist international 

partners in establishing and 

maintaining, HIV/AIDS, viral hepatitis, 

STDs, and TB screening, treatment, 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 62555 

immunization, and other prevention 

and control programs; (19) ensures that 

programmatic and scientific activities 

are aligned with, and in support of, 

CDC’s overall mission, goals, and 

strategic imperatives; (20) allocates and 

tracks CDC resources and contributes to 

the development of CDC’s short-, 

medium- and long-term strategic plans 

for preventing the spread of HIV/AIDS, 

viral hepatitis, STDs, and TB; (21) 

collaborates with other federal agencies, 

domestic and international 

governmental and non-governmental 

organizations to advance CDC and 

NCHHSTP health protection goals; and 

(22) coordinates oversight of the 

NCHHSTP Federal Advisory 

Committees. 

Office of the Director (CVJ1). (1) 

Provides leadership and guidance on 

the development of goals and objectives, 

policies, program planning and 

development, and program management 

and operations of the activities of 

NCHHSTP and manages, directs, 

coordinates, and evaluates the center’s 

activities; (2) plans and coordinates the 

annual program planning process; (3) 

coordinates with Office of the Director 

(OD), Centers/Institute/Offices (CIOs), 

and divisions in determining and 

interpreting operating policy and in 

ensuring their respective management 

input for specific program activity 

plans; (4) facilitates CIOser linkages 

between HIV, non-HIV retroviruses, 

STDs, viral hepatitis, and TB, 

surveillance activities and prevention 

programs at all levels, and facilitates 

collaboration, integration, and multidisciplinary approaches to enhance the 

effectiveness of HIV, STD, viral 

hepatitis, and TB prevention programs; 

(5) facilitates collaboration among, and 

integration of, science and prevention 

programs throughout NCHHSTP and 

enhances the coordination and 

integration of HIV, STD, viral hepatitis, 

and TB prevention services for 

individuals and populations at 

increased risk for more than one of these 

infections; (6) coordinates the 

integration of CDC funding of state and 

local health departments for HIV, STD, 

viral hepatitis, and TB prevention; (7) 

maximizes center-wide collaboration to 

promote and support Program 

Collaboration and Service Integration 

(PCSI) in state and local HIV/AIDS, viral 

hepatitis, STD and TB programs to 

increase efficiencies and provide 

comprehensive evidence based 

prevention services to impacted 

populations; (8) develops partnership 

objectives and strategies for advancing 

center priorities (e.g., on cross-cutting 

functions PCSI, reducing health 

disparities, etc.) and leverages OD 

resources to address these objectives 

and strategies; (9) coordinates and tracks 

health equity science and program 

activities within the center; (10) 

coordinates and tracks science and 

program activities that concern or 

address social determinants of health 

within NCHHSTP and other programs; 

(11) collaborates with the CDC OD and 

other CDC components on health equity 

activities, and works with the CDC OD 

to monitor progress in meeting 

Executive Orders related to improving 

minority health; (12) develops 

partnerships with other federal agencies 

and nongovernmental organizations 

working on similarly-affected 

populations; (13) supports research, 

surveillance, education, training, and 

program development to achieve health 

equity and reduce health disparities; 

(14) sponsors workgroups, meetings, 

and conferences related to health equity; 

(15) promotes a diverse public health 

workforce through internships, 

fellowships, training programs, and 

other activities; (16) ensures process 

consistency for laboratory related 

functions within NCHHSTP and across 

the CIOs; (17) facilitates cross-center 

decision-making regarding laboratory 

activities; (18) monitors the performance 

of funded extramural research projects 

in the areas of HIV/AIDS, viral hepatitis, 

STD and TB; (19) collaborates with 

other federal agencies to advance 

prevention through healthcare; (20) 

coordinates and supports cross-cutting 

strategic initiatives in support of 

NCHHSTP divisions and partners; and 

(21) works across the agency to advance 

prevention priorities. 

After the functional statement for the 

Office of the Director (CVJ1), insert the 

following: 

Office of the Associate Director for 

Science (CVJ12). (1) Ensures process 

consistency for science across the CIOs; 

(2) facilitates cross-center decisionmaking regarding science; (3) facilitates 

communication regarding scientific and 

programmatic services across the Office 

of Infectious Diseases (OID); (4) 

conducts necessary regulatory and 

ethical reviews for activities involving 

human participants, including 

determining whether an activity 

includes research, includes human 

subjects, is exempt or requires 

Institutional Review Board approval, 

and whether an exception is needed to 

the Public Health Service HIV policy; 

(5) reviews funded activities for 

application of human research 

regulations; (6) reviews, approves, and 

tracks research protocols, clinical 

investigations, and the Food and Drug 

Administration regulated response 

activities intended for submission to 

CDC Human Research Protections 

Office; and (7) coordinates and tracks 

Office of Management and Budget 

clearance under the Paperwork 

Reduction Act. 

Informatics Office (CVJ13). (1) 

Manages all information technology (IT) 

project costs, schedules, performances, 

and risks; (2) provides expertise in 

leading application development 

techniques in information science and 

technology to effect the best use of 

resources; (3) performs technical 

evaluation and integrated baseline 

reviews of all information systems’ 

products and services prior to 

procurement to ensure software 

purchases align with NCHHSTP 

strategy; (4) provides access to quality 

data in support of programmatic data 

analysis; (5) coordinates all enterprisewide IT security policies and 

procedures with key agency offices; (6) 

ensures operations are in accordance 

with CDC Capital Planning and 

Investment Control guidelines; (7) 

ensures adherence to CDC enterprise 

architecture guidelines and standards; 

(8) consults with users to determine IT 

needs and to develop strategic and 

action plans; and (9) participates in the 

evolution, identification, development, 

or adoption of appropriate informatics 

standards. 

Extramural Research Program Office 

(CVTJJ14). (1) Serves as the focal point 

for the OID for implementing policies 

and guidelines for the conduct of the 

peer review of infectious disease 

extramural research grant proposals and 

subsequent grant administration; (2) 

coordinates and conducts in-depth 

external peer review and secondary 

program relevance review of extramural 

research applications by use of 

consultant expert panels; (3) makes 

recommendations to the appropriate 

infectious disease center director on 

award selections and staff members 

serve as the program officials in 

conjunction with CDC grants 

management and policy officials to 

implement and monitor the scientific, 

technical, and administrative aspects of 

awards; (4) facilitates scientific 

collaborations between external and 

internal investigators; (5) disseminates 

and evaluates extramural research 

progress, findings, and impact; and (6) 

coordinates and executes objective 

review, including the special emphasis 

panel (SEP) process for funding of CDC 

infectious disease non-research grants 

and cooperative agreements. 

Office of Management and Program 

Support (CVJ15). (1) Helps implement 

and enforce management and operations 

policies and guidelines developed by 


srobinson on DSKHWCL6B1PROD with NOTICES
62556 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 

federal agencies, DHHS, and Staff 

Service Offices (SSO); (2) plans, 

develops, implements, and provides 

oversight and quality control for centerwide policies, procedures, and practices 

for administrative management and 

acquisition and assistance mechanisms, 

including contracts, memoranda of 

agreement, and cooperative agreements; 

(3) provides management and 

coordination of NCHHSTP-occupied 

space and facilities; (4) supplies 

technical guidance and expertise 

regarding occupancy and facilities 

management to emergency situations; 

(5) provides oversight and management 

of the distribution, accountability, and 

maintenance of CDC property and 

equipment; (6) provides oversight, 

quality control, and management of 

NCHHSTP records; (7) serves as lead 

and primary contact and liaison with 

relevant SSO on all matters pertaining 

to the center’s procurement needs, 

policies, and activities; (8) develops, 

reviews, and implements policies, 

methods and procedures for NCHHSTP 

non-research extramural assistance 

programs; (9) interprets general policy 

directives, proposed legislation, and 

appropriation language for implications 

on management and execution of 

center’s programs; (10) provides 

consultation and technical assistance to 

NCHHSTP program officials in the 

planning, implementation, and 

administration of assistance programs; 

(11) develops and implements objective 

review processes, including use of SEP 

process for competitive application 

cycles; (12) oversees the formulation of 

the NCHHSTP budget and responds to 

inquiries related to the budget; (13) 

provides technical information services 

to facilitate dissemination of relevant 

public health information and facilitates 

collaboration with national health 

activities, CDC components, other 

agencies and organizations, and foreign 

governments on international health 

activities; (14) provides oversight for the 

programmatic coordination of HIV, STD, 

viral hepatitis, and TB activities 

between NCHHSTP and other CIOs; 

develops recommendations to the CDC 

Director as the lead CIO for these 

programs for the distribution of HIV, 

STD, viral hepatitis, and TB funds CDCwide; (15) provides guidance and 

coordination to divisions on crossdivisional negotiated agreements; (16) 

facilitates state and local crossdivisional issues identification and 

solutions; (17) in coordination with the 

Office of Program Planning and Policy 

Coordination, responds to Congress as 

needed; (18) serves as NCHHSTP liaison 

to relevant SSOs for all matters related 

to financial management; (19) serves as 

focal point for emergency operations 

and deployment; (20) manages and 

coordinates workforce development and 

succession planning activities within 

NCHHSTP in collaboration with 

internal and external partners, and 

coordinates the recruitment, 

assignment, technical supervision, and 

career development of staff with 

emphasis on developing and supporting 

diversity initiatives and equal 

opportunity goals; (21) facilitates the 

assignment of field staff in accordance 

with CDC and NCHHSTP priorities and 

objectives and reassesses the role of 

NCHHSTP field staff assignees to state 

and local health jurisdictions; and (22) 

provides center-wide training to 

supervisors, managers and team leaders. 

Office of Program Planning and Policy 

Coordination (CVJ16). (1) Identifies 

program priorities through strategic 

planning and other processes as 

appropriate; (2) oversees the 

development of the center’s 

performance plan and performance 

reports to ensure accountability and 

improve programs and activities; (3) 

coordinates with the center director and 

management officer the formulation of 

the NCHHSTP budget; (4) liaises with 

the CDC SSOs on Congressional, 

legislative, and other inquiries; (5) 

maintains liaison with Congress on 

matters including appropriations, 

legislative bill tracking, and legislative 

requests, testimony for hearings, 

congressional inquiries, etc.; (6) 

develops policy- and program-related 

materials, and talking points; (7) 

oversees the preparation and routing of 

controlled correspondence; (8) 

maintains liaison with key CDC offices 

and individuals working on public 

health policies and legislative issues; (9) 

serves as liaison to governmental and 

nongovernmental partners on policyrelated issues; (10) oversees priority 

issues management and proactive and 

reactive strategic media efforts; (11) 

conducts environmental analysis in 

response to short-term issues to be 

shared with leadership and program 

managers; (12) works with the Health 

Communication Science Office to 

coordinate communication strategy and 

manage short-term issues; (13) 

formulates strategic media objectives for 

advancing program priorities and 

addressing identified long-range issues; 

and oversees the implementation of 

strategic media plans through several 

functional areas; (14) develops and 

implements all proactive media 

outreach and reactive media responses 

for the center; (15) provides media 

training and technical assistance, as 

appropriate; and (16) serves as liaison to 

key offices for obtaining CDC and HHS 

media clearance on products/activities. 

Health Communication Science Office 

(CVJ17). (1) Serves as the principal 

advisor to NCHHSTP on communication 

and marketing science, research and 

practice; (2) provides oversight to 

ensure the quality and science of health 

communication and marketing 

campaigns and products created by 

NCHHSTP and its divisions; (3) serves 

as NCHHSTP clearance office for health 

communication campaigns and 

products; develops and manages 

clearance systems; (4) provides strategic 

planning and coordination for 

NCHHSTP communication and 

marketing programs in collaboration 

with OD and division-level staff; (5) 

collaborates with NCHHSTP policy and 

media relations staff to ensure 

consistent and timely translation of 

center-specific health information; (6) 

executes communication activities to 

support strategic goals and objectives of 

the NCHHSTP OD and activities to 

support division-level programs; (7) 

coordinates and provides center input 

on communication activities; (8) 

coordinates CDC and NCHHSTP brand 

management; (9) provides oversight and 

consultation on partnership 

development and partner/stakeholder 

communication; (10) develops and 

manages partner relationships in 

collaboration with NCHHSTP divisions 

and CDC CIOs; (11) coordinates 

partnership strategies across NCHHSTP 

divisions; (12) manages communication 

infrastructure for NCHHSTP 

partnerships; (13) oversees management, 

policy guidance, and governance of 

NCHHSTP digital channels and Web 

sites per HHS and CDC policy for the 

use of communication technologies; (14) 

provides coordination and conducts 

activities to support NCHHSTP’s 

presence on networked media, such as 

social and mobile media; and (15) 

collects/analyzes user data/metrics from 

communication channels and 

technologies to assess system 

performance, usability, accessibility, 

and usefulness. 

Delete items (15) and (16) of the 

functional statement for the Office of the 

Director (CVJB 1), Division of HIV/ 

AIDS, Prevention-Intervention Support 

(CVJB), and insert the following: (15) 

Collaborates with other branches, 

divisions, and CIOs to synthesize HIV 

prevention research findings and 

translate them into prevention practice; 

and (16) collaborates, as appropriate, 

with other divisions and offices of 

NCHHSTP, and with other CIOs 

throughout CDC in carrying out these 

activities. 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 62557 

Delete item (1) of the functional 

statement for the Prevention Program 

Branch (CVJBC), and insert the 

following: (1) In collaboration with state 

and local public health and nongovernmental national/regional and 

local partners, CIOs, and other federal 

agencies, develops and implements 

programs, policies, and activities that 

enable and mobilize affiliates and 

communities to become involved with, 

and support, local and statewide 

strategic community planning that 

improves HIV prevention programs and 

activities. 

Delete in its entirety the title and 

function statement for the Program 

Evaluation Research Branch (CVJBD), 

and insert the following: 

Program Evaluation Branch (CVJBD). 

(1) Evaluates the effectiveness and 

impact of HIV prevention interventions, 

strategies, policies, and programs as 

practiced or implemented by CDCfunded public health agencies and 

organizations at the national/regional 

and state/local levels; (2) collaborates 

within DHAP, with HIV prevention 

program grantees, and with other 

national partners to systematically 

collect, process, and use HIV prevention 

program data for program planning and 

improvement; (3) collaborates in the 

conduct of evaluation research activities 

and economic evaluations of HIV 

prevention activities; (4) seeks to 

advance the methodology of HIV 

prevention evaluation through CDC 

evaluation activities and with the field 

of program evaluation more broadly; 

and (5) collaborates with other branches 

as they develop, test, and disseminate 

models for quality assurance of 

programs and services. 

Delete in its entirety the title and 

function statement for the Technical 

Information and Communications 

Branch (CVJBG), and insert the 

following: 

Prevention Communications Branch 

(CVJBG). (1) Implements science and 

evidence based HIV/AIDS 

communication programs and 

approaches that target opinion leaders, 

stakeholders, persons at risk for and 

living with HIV/AIDS and the general 

public; (2) systematically translates and 

disseminates science based messages 

through multiple communication 

channels; (3) effectively implements 

agenda setting and mobilization efforts; 

and (4) implements efficient internal 

communication approaches targeting 

DHAP staff. 

Delete items (3) and (10) of the 

functional statement for the Office of the 

Director (CVJC 1), Division of HIV/ 

AIDS, Prevention-Surveillance and 

Epidemiology (CVJC) and insert the 

following: (3) Provides leadership in 

developing research in epidemiology, 

surveillance, and other scientific aspects 

of HIV/AIDS prevention, and in 

coordinating activities between the 

division and other NCHHSTP divisions, 

CIOs, and national-level prevention 

partners who influence HIV/AIDS 

prevention programs involved in HIV/ 

AIDS investigations and research; and 

(10) collaborates, as appropriate, with 

other divisions and offices of 

NCHHSTP, and with other CIOs 

throughout CDC. 

After item (10) of the functional 

statement for the Office of the Director 

(CVJD1), Division of Sexually 

Transmitted Disease Prevention (CVJD), 

add the following: and (11) manages the 

Tuskegee Participants Health Benefits 

Program. 

After the functional statement for the 

Statistics and Data Management Branch 

(CVJDH), add the following: 

Field Services Branch (CVJDJ). (1) In 

collaboration with the Program and 

Training Branch assigns Public Health 

Advisors to state and local health 

departments; (2) provides state and local 

health departments technical assistance 

with the development and 

implementation of strategies for 

addressing the STD burden; (3) provides 

state and local health departments 

assistance with developing, 

implementing and evaluating core 

public health activities to reduce the 

incidence, strengthen public, private 

clinical and community-based 

partnerships; and (4) promotes and 

enhances capacity-building within state 

and local health departments through 

consultation, demonstration and 

technical expertise. 

Delete in their entirety the functional 

statements for the Division of 

Tuberculosis and Elimination (CVJE), 

and Office of Director (CVJE1), and 

insert the following: 

Division of Tuberculosis Elimination 

(CVJE). The Division of Tuberculosis 

Elimination (DTBE) promotes health 

and quality of life by preventing, 

controlling, and eventually eliminating 

TB from the United States (U.S.), and by 

collaborating with other countries and 

international partners in controlling TB 

worldwide. In carrying out its mission, 

the division conducts the following 

activities under each focus area: (1) 

Administers and promotes a national 

program for the prevention, control, and 

elimination of TB; (2) supports a 

nationwide framework for surveillance 

of TB and evaluation of national TB 

prevention and control program 

performance; (3) provides programmatic 

consultation, technical assistance, and 

outbreak response assistance to 

international, state, and local TB 

programs; (4) co-chairs and coordinates 

administrative support for the Federal 

TB Task Force, and supports and 

collaborates with the National 

Tuberculosis Controllers Association 

and the Tuberculosis Education and 

Training Network to promote effective 

national communications and 

coordinated feedback on urgent policy 

and program performance issues; (5) 

supports development of TB patient 

education materials and interventions, 

capacity development, and access to 

medical consultation; (6) provides 

national and supranational reference 

laboratory function for identification, 

drug susceptibility testing of 

Mycobacterium tuberculosis; (7) fosters 

patient-centered measures, including 

directly-observed therapy, to promote 

adherence with long-term treatment for 

improvements in well-being and 

interruption in community transmission 

of M tuberculosis; (8) promotes targeted 

testing of idemiologically-defined at-risk 

populations and treatment of persons 

with latent TB; (9) conducts 

epidemiologic, laboratory, behavioral, 

health systems, and clinical research; 

(10) supports patient and provider 

research to identify barriers and 

facilitators to TB services; (11) supports 

multicenter consortia for epidemiologic, 

laboratory, diagnostics, clinical, and 

vaccine development research; (12) 

develops and applies mathematical TB 

transmission models to forecast future 

incidence and prevalence trends; (13) 

provides leadership and formulates 

national and global policies and 

guidelines; (14) provides technical 

supervision and training to federal 

assignees working in international, 

state, and local TB control programs; 

(15) develops training and educational 

materials, and provides technical 

assistance on communications and 

training needs; (16) participates in the 

development of policies and guidelines 

for TB prevention and control within 

populations at high risk, such as 

persons infected with HIV or racial and 

ethnic minorities; (17) provides 

programmatic consultation, technical 

assistance, and outbreak response 

assistance to other countries by 

collaborating with national and 

international partners; (18) supports 

technical activities and operational 

research to reduce TB in foreign-born 

populations; (19) provides leadership 

and technical support to the global 

health initiatives for the prevention and 

control of TB and drug-resistant TB; 

(20) provides leadership and technical 

support to the World Health 

Organization (WHO)-hosted Stop TB 


srobinson on DSKHWCL6B1PROD with NOTICES
62558 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 

Partnership for implementation of the 

Global Plan to Stop TB and Millennium 

Development Goals; (21) monitors 

progress and trends towards TB 

elimination; (22) monitors progress 

towards CDC, Healthy People 2010, and 

the Government Performance Results 

Act goals; (23) provides progress reports 

to, and solicits advice from, the 

Advisory Council for the Elimination of 

Tuberculosis (ACET); and (24) facilitates 

partnerships with affected communities, 

nongovernmental, professional, and 

global organizations. 

Office of the Director (CVJE1). (1) 

Provides leadership and guidance in 

program planning and management, 

policy formulation, and development of 

training, surveillance, and research 

programs in TB; (2) directs and 

evaluates the operations of the division; 

(3) establishes contact with, and 

promotes TB activities of, other national 

and international organizations which 

have an important role to play in 

achieving TB elimination; (4) 

coordinates administrative and 

logistical support services for the 

division; (5) provides consultation and 

assistance in writing reports for 

presentation at local, regional, national, 

and international scientific meetings 

and for publication in scientific 

journals; (6) coordinates and tracks 

materials for purposes of clearance and 

approval for publications and 

presentations; (7) presents findings at 

national and international scientific 

meetings; (8) presents division overview 

at the ACET meetings; (9) collaborates 

and coordinates division activities with 

other components of NCHHSTP and 

CDC; (10) provides technical support to 

ACET; (11) provides administrative and 

technical support for the Stop TB USA 

(previously the National Coalition for 

the Elimination of Tuberculosis) and the 

Federal TB Task Force; and (12) 

provides leadership and technical 

expertise to the global Stop TB 

partnership. 

Delete in its entirety the functional 

statement for the Communications, 

Education, and Behavioral Studies 

Branch (CVJEB), and insert the 

following: 

(1) Provides technical assistance to 

health departments and other health 

care providers in assessing and meeting 

their TB training, education, and 

communication needs; (2) provides 

technical expertise to assess the impact 

of training and education activities by 

health departments; (3) provides 

technical assistance to health 

departments and other TB health care 

providers regarding behavioral studies 

research and intervention development; 

(4) collaborates with the WHO, the 

World Bank, the International Union 

Against Tuberculosis and Lung Diseases 

(IUATLD), United States Agency for 

International Development (USAID), 

and others, in assessing and meeting TB 

training, education, and communication 

needs in other countries; (5) provides 

consultation and assistance in 

coordinating TB training, education, 

behavioral studies and interventions, 

and communication activities carried 

out by other CDC programs, Regional 

Training and Medical Consultation 

Centers, and Stop TB USA members, 

and develops, markets, and maintains 

electronic mailing lists for persons with 

TB-related education, training, and 

communication responsibilities; (6) 

develops, plans, and coordinates 

agendas necessary to conduct TB 

conferences and workshops sponsored 

by the division; (7) provides DTBE 

coordination and oversight and 

technical information for CDC INFO; (8) 

organizes and maintains scientific and 

non-scientific information resources 

related to TB; (9) conducts formative 

research and evaluation on approaches 

to patient, provider, and public 

education, and conducts research on 

individual and social factors affecting 

health-care seeking behavior and 

treatment outcomes related to TB; (10) 

based on research findings, develops 

behavioral interventions targeted to 

health care providers, persons with or at 

risk for TB, and other high-risk 

populations; (11) provides consultation 

to national and international 

organizations on behavioral research 

needs and study designs; on the 

technical transfer of behavioral research 

findings into TB program practice and 

TB training and educational strategies; 

and provides consultation, technical 

assistance, and coordination to other 

branches within the division regarding 

development and implementation of 

behavioral interventions and training for 

branch specific activities such as Report 

of Verified Case of Tuberculosis, 

Aggregate Reports for Program 

Evaluation, and surveillance activities; 

(12) presents findings at national and 

scientific meetings and develops, 

disseminates, and evaluates training and 

educational materials and courses 

providing TB information to the 

scientific and public health 

communities, as well as the general 

population; (13) conducts training and 

education needs assessments; identifies 

resources available for health 

department TB control officers and 

senior managers, TB nurse consultants, 

TB training and education directors and 

for senior staff carrying out TB activities 

in other programs or facilities serving 

persons at high risk for TB; and 

develops, conducts, and coordinates 

training courses on TB for state and big 

city TB program managers and nurse 

consultants; (14) based on needs 

assessments, develops and conducts or 

coordinates training courses and 

materials for staff who train and/or 

supervise front-line TB program staff 

(15) provides oversight in the planning, 

coordination, and maintenance of the 

division’s Internet and Intranet Web 

sites; (16) conducts and/or coordinates 

communications programs designed to 

build public support and sustain public 

interest and commitment to the 

elimination of TB; (17) conducts 

communications research and identifies 

communications resources available for 

health department TB control officers 

and senior managers, TB nurse 

consultants, and for senior staff carrying 

out TB activities in other programs or 

facilities serving persons at high risk for 

TB; (18) coordinates graphic support to 

the division and senior field staff; (19) 

provides coordination and oversight for 

division responses and relations with 

the media and public and serves as 

point of contact for telephonic, written, 

and electronic (e-mail) requests for 

information from the media and public; 

(20) develops, coordinates, and staffs 

the divisions exhibit booth at 

conferences/meetings; (21) provides 

oversight and coordination for TB 

related voice and Web-based TB 

information, training, and education 

resources; (22) maintains inventory of 

TB training opportunities and 

coordinates with employees and 

supervisors for training necessary to 

carry out their duties; and (23) presents 

communications issues to ACET and at 

national and international scientific 

meetings. 

Delete in its entirety the title and 

function statement for the Clinical and 

Health Systems Research Branch 

(CVJEE), and insert the following: 

Clinical Research Branch (CVJEE). 

(1) Assesses the need for and conducts 

studies of new or existing drugs and 

regimens used in the prevention and 

treatment of TB, including dosage, 

duration, pharmacokinetics and 

toxicity; (2) supports the TB Trials 

Consortium in the conduct of studies of 

new treatments for active TB and latent 

TB infection; (3) supports coordinated 

and standardized data management for 

branch research, and serves as the Data 

and Coordinating Center for the TB 

Trials Consortium, collaborating as 

needed with both internal and external 

partners; (4) collaborates with private 

and public institutions in the area of 

vaccine development; (5) provides 

clinical support and oversight for the 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 62559 

distribution of investigational drugs for 

the treatment and prevention of TB by 

CIOs/Scientific Resources/Drug Service; 

(6) assesses the need for and conducts 

clinical and field trials of more specific 

and rapid tests to diagnose active TB 

and latent TB infection and to identify 

drug-resistant TB in collaboration with 

the Laboratory Branch; (7) collaborates 

with and provides consultation and 

technical assistance to national and 

international organizations on the 

design and conduct of clinical trials and 

research needs; (8) conducts, 

participates in, and collaborates with 

other DTBE units in research on 

clinical, epidemiologic, immunologic 

and genetic aspects of TB prevention 

and control; (9) collaborates in contact 

investigation research with other 

branches and local programmatic areas; 

(10) conducts multidisciplinary studies 

(including the analysis of behavioral, 

economic, and epidemiologic factors) of 

health care systems to assess the cost, 

effectiveness, and impact of public 

health policies, programs, and practices 

on TB outcomes to further the goal of 

TB elimination in the U.S., and targets 

these studies toward various 

populations at high risk for TB, 

including persons from high TB 

prevalent countries, homeless persons, 

HIV-infected persons, residents of 

correctional facilities, substance 

abusers, and health care workers; (11) 

provides consultation and training to 

local, state, national, and international 

organizations, and to TB program field 

staff, on design and conduct of clinical 

trials, TB therapeutics and diagnostics, 

health care systems research needs, 

decision and economic analyses, 

evaluation techniques, qualitative 

research methods, and research on TB 

transmission; (12) has responsibility for 

divisional engagement in preparing for 

and participating in trials of new TB 

vaccines; (13) reports study results to 

public health practitioners through 

direct communication, articles in 

scientific journals and CDC 

publications, and oral and poster 

presentations at national and 

international scientific meetings; (14) 

provides input into statements and 

guidelines issued by the CDC, the 

ACET, and professional organizations; 

and (15) presents research issues and 

findings to ACET and at national and 

international scientific meetings. 

Delete items (2), (3), (4), and (6) of the 

functional statement for the 

International Research and Programs 

Branch (CVJEI1D), and insert the 

following: (2) Coordinates the 

assessment of immigration and its 

impact on TB patterns in the U.S. and 

assists with the evaluation of overseas 

TB screening procedures for immigrants 

and refugees; (3) conducts and 

coordinates operational research and 

demonstration projects to improve both 

the overseas screening for TB of 

immigrants and refugees and the 

domestic follow-up of those entering 

with suspected TB (in collaboration 

with other CIOs); (4) promotes the 

improved recognition and management 

of TB among the foreign-born through 

epidemiological analyses of national TB 

surveillance data and special studies on 

the U.S./Mexico border and in countries 

contributing to foreign-born TB cases in 

the U.S.; (6) collaborates with the nation 

of Botswana, WHO, the World Bank, 

IUATLD, USAID, and others, to conduct 

investigations into the diagnosis, 

management, and prevention of TB in 

persons with and without HIV infection. 

Delete in its entirety the title and 

function statement for the 

Mycobacteriology Laboratory Branch 

(CVJEJ), and insert the following: 

Laboratory Branch (CVJEJ). (1) Serves 

as the national reference laboratory in 

support of the mission of DTBE, 

fulfilling public health function in 

leadership, clinical and consultative 

service, and research; (2) provides 

laboratory support for epidemic 

investigations, surveillance activities, 

and special studies of TB, in 

collaboration of other branches; (3) 

administers contracts to provide 

Mycobacterium tuberculosis 

genotyping, maintains a national 

database of genotypes, and conducts 

operational research to implement 

genotyping; (4) develops and evaluates 

new methods to subtype M tuberculosis 

for epidemiologic studies; (5) serves as 

primary CDC focus for diagnostic 

laboratory services for TB; (6) 

administers grants and cooperative 

agreements with states and others to 

upgrade laboratory activities and 

provide special services; (7) provides 

reference diagnostic services, 

consultation, technical assistance, and 

training to state, federal, and municipal 

public health laboratories; (8) provides 

laboratory support, reference services, 

assessment, consultation, and training 

for CDC’s international TB activities; (9) 

develops, evaluates, or improves 

conventional and molecular methods for 

the detection, classification, 

identification, characterization, and 

susceptibility testing of M tuberculosis; 

(10) conducts studies to define the role 

of bacterial virulence factors, host 

factors, and pathogenic and 

immunologic mechanisms in disease 

processes and protective immunity in 

mycobacteria, and develops, evaluates, 

and improves immunologic methods for 

the diagnosis and prevention of TB; (11) 

develops tissue culture and animal 

models of TB and conducts studies on 

chemotherapy, immunotherapy, 

pathogenesis, pathology, and vaccines 

for TB; (12) prepares manuscripts for 

publication in scientific journals; (13) 

presents findings at national and 

international scientific meetings; (14) 

supervises and trains fellows in 

temporary or multi-year educationallybased programs in endeavors related to 

the mission of the branch; and (15) 

presents laboratory issues to ACET and 

at national and international scientific 

meetings. 

Dated: September 27, 2010. 

William P. Nichols, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2010–25427 Filed 10–8–10; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

Statement of Organization, Functions, 

and Delegations of Authority 

Part J (Agency for Toxic Substances 

and Disease Registry) of the Statement 

of Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (50 FR 25129–25130, dated 

June 17, 1985, as amended most 

recently at 73 FR 20293, dated April 15, 

2008) is amended to reflect the 

reorganization of the Agency for Toxic 

Substances and Disease Registry. 

Section J–B, Organization and 

Functions, is hereby amended as 

follows: After the title and function 

statement for the Office of Policy, 

Planning, and Evaluation (JAA3), Office 

of the Director (JAA), Office of the 

Administrator (JA), Agency for Toxic 

Substances and Disease Registry (J), 

insert the following: 

Office of Communication (JAA7). The 

Office of Communication (OC): (1) 

Serves as the principal advisor to the 

Agency Assistant Administrator and 

divisions on communication and 

marketing science, research, practice, 

and public affairs; (2) leads agency 

strategic planning for communication 

and marketing science and public affairs 

programs and projects; (3) analyzes 

context, situation, and environment to 

inform agency-wide communication and 

marketing programs and projects; (4) 

ensures use of scientifically sound 

research for marketing and 

communication programs and projects; 


srobinson on DSKHWCL6B1PROD with NOTICES